Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2005; 11(45): 7159-7164
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7159
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7159
GSD (yes vs no) | ||||||||
Male | Female | |||||||
Crude OR (95%CI) | Age-adjusted OR (95%CI) | Crude OR (95%CI) | Age-adjusted OR (95%CI) | |||||
Age (≥65 vs <65 yr) | 3.14 | (1.32-7.47)a | - | - | 2.25 | (1.04-4.90)a | - | - |
Type 2 diabetes (known vs new cases) | 0.90 | (0.34-2.39) | 0.87 | (0.32-2.34) | 1.44 | (0.68-3.02) | 1.46 | (0.68-3.13) |
FPG (≥11.1 vs <11.1 mmol/L) | 2.12 | (0.70-6.37) | 1.95 | (0.64-5.94) | 1.24 | (0.50-3.07) | 1.49 | (0.59-3.79) |
SBP (≥140 vs <140 mmHg) | 1.70 | (0.73-3.97) | 1.50 | (0.63-3.56) | 2.59 | (1.23-5.46)a | 1.99 | (0.92-4.31) |
DBP (≥90 vs <90 mmHg) | 1.44 | (0.62-3.35) | 1.57 | (0.67-3.73) | 1.12 | (0.52-2.42) | 1.21 | (0.55-2.67) |
Obesity (yes vs no) | 2.04 | (0.85-4.88) | 2.00 | (0.83-4.83) | 2.97 | (1.30-6.83)a | 2.88 | (1.24-6.70)a |
Central obesity (yes vs no) | 2.76 | (1.13-6.77)a | 2.36 | (1.01-5.97) | 1.85 | (0.68-5.02) | 1.47 | (0.53-4.09) |
Cholesterol (≥5.17 vs <5.17 mmol/L) | 1.02 | (0.19-1.91) | 0.88 | (0.18-1.09) | 0.92 | (0.45-1.88) | 0.85 | (0.41-1.77) |
Triglyceride (≥2.24 vs <2.24 mmol/L) | 1.92 | (0.12-2.36) | 1.61 | (0.13-2.84) | 1.43 | (0.20-2.46) | 1.35 | (0.15-1.96) |
BUN (≥7.14 vs <7.14 mmol/L) | 0.44 | (0.16-1.25) | 0.38 | (0.13-1.09) | 1.65 | (0.75-3.61) | 1.30 | (0.58-2.93) |
Uric acid (high vs normal) | 0.30 | (0.09-1.06) | 0.29 | (0.08-1.03) | 1.61 | (0.77-3.38) | 1.12 | (0.51-2.48) |
AST (≥40 vs <40 U/L) | 1.05 | (0.08-5.72) | 0.60 | (0.07-5.31) | 3.68 | (1.01-9.32)a | 3.93 | (1.04-10.89)a |
ALT (≥40 vs <40 U/L) | 1.09 | (0.19-4.33) | 1.09 | (0.21-5.61) | 2.00 | (0.67-6.02) | 2.20 | (0.71-6.85) |
Serum insulin (2ndvs 1st quartile) | 0.29 | (0.06-1.33) | 0.30 | (0.06-1.39) | 1.39 | (0.44-4.40) | 1.68 | (0.52-5.45) |
(μU/mL) (3rdvs 1st quartile) | 0.61 | (0.19-2.00) | 0.56 | (0.17-1.86) | 2.05 | (0.71-5.88) | 2.20 | (0.75-6.45) |
(4thvs 1st quartile) | 0.61 | (0.18-2.03) | 0.65 | (0.20-2.17) | 5.38 | (2.14-13.48)a | 5.32 | (2.08-13.64)a |
Log HOMA IR (2ndvs 1st quartile) | 0.61 | (0.19-2.00) | 0.60 | (0.18-1.99) | 1.17 | (0.38-3.57) | 1.65 | (0.52-5.29) |
(3rdvs 1st quartile) | 0.58 | (0.06-1.29) | 0.49 | (0.06-1.36) | 2.60 | (1.02-6.64)a | 2.66 | (1.02-6.94)a |
(4thvs 1st quartile) | 0.63 | (0.19-2.08) | 0.60 | (0.18-2.01) | 2.60 | (1.01-6.66)a | 2.59 | (1.01-6.76)a |
Log HOMA β-cell (2ndvs 1st quartile) | 1.16 | (0.35-3.80) | 1.27 | (0.38-4.25) | 0.35 | (0.08-1.55) | 0.45 | (0.10-2.03) |
(3rdvs 1st quartile) | 0.52 | (0.11-2.43) | 0.51 | (0.11-2.39) | 0.16 | (0.02-1.23) | 0.17 | (0.02-1.35) |
(4thvs 1st quartile) | 0.25 | (0.03-2.97) | 0.22 | (0.03-1.73) | 0.17 | (0.02-1.28) | 0.16 | (0.02-1.21) |
- Citation: Liu CM, Tung TH, Tsai ST, Liu JH, Tsai YK, Chen VTK, Tam TN, Lu HF, Wang KK, Hsu CT, Shih HC, Chan DC, Chou P. Serum insulin, insulin resistance, β-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: A community-based study in Kinmen, Taiwan. World J Gastroenterol 2005; 11(45): 7159-7164
- URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7159